Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 50.40
-1.20 (-2.33%)
Jul 30, 2026, 2:15 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 10.26 billion as of July 29, 2026. Its market cap has decreased by -27.59% in one year.
Market Cap
10.26B
Enterprise Value
8.85B
Revenue
197.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.40
ChartMarket Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 10.26B, a decrease of -20.90%. That is a compound annual growth rate of -20.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 10.26B | 1.18% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 13.10B |
| Metis TechBio | 12.06B |
| HBM Holdings | 10.76B |
| GenFleet Therapeutics (Shanghai) | 10.27B |
| Ascletis Pharma | 9.49B |
| Shaanxi Micot Pharmaceutical Technology | 9.34B |
| Everest Medicines | 8.79B |
| TenNor Therapeutics (Suzhou) | 8.78B |